MiR-25/RhoGDI1 axis provides new insight into the pathogenesis of HCC, particularly with respect to invasion and metastasis, and represents a potential therapeutic target for the treatment of HCC. This evidence concerns the gene ARHGDIA and hepatocellular carcinoma.